NCT01002586 is a NA clinical trial of Wii-Fit intervention in Alzheimer's Dementia, sponsored by University of Nebraska.

Who is sponsoring NCT01002586?

NCT01002586 is sponsored by University of Nebraska.

What drugs are being tested in NCT01002586?

Interventions in NCT01002586: Wii-Fit intervention, Walking exercise program.

What condition does NCT01002586 study?

NCT01002586 studies Alzheimer's Dementia, Falls, Gait Impairment, Balance Impairment.

Is NCT01002586 still recruiting?

NCT01002586 is currently completed. Last updated 2 April 2024.

Last reviewed 2024-04-02 · How we verify

NCT01002586

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Wii-Fit For Improving Activity, Gait And Balance In Alzheimer's Dementia

Completed NA Last updated 2 April 2024

What this trial tests

NA trial testing Wii-Fit intervention in Alzheimer's Dementia in 22 participants. Completed in 6 July 2012.

Timeline

1 November 2009

Primary endpoint
6 July 2012

6 July 2012

Quick facts

Lead sponsor	University of Nebraska
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	22
Start date	1 November 2009
Primary completion	6 July 2012
Estimated completion	6 July 2012
Sites	1 location across United States

Drugs / interventions tested

Wii-Fit intervention
Walking exercise program

Conditions studied

Alzheimer's Dementia — all drugs for Alzheimer's Dementia →
Falls — all drugs for Falls →
Gait Impairment — all drugs for Gait Impairment →
Balance Impairment — all drugs for Balance Impairment →

Sponsor

University of Nebraska

Who can join

60 and older, any sex, with Alzheimer's Dementia or Falls. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Alzheimer's Dementia (AD) contributes to poor balance, impaired gait and functional status, thereby, increasing the risk of falls. AD is an independent risk factor for hip fractures. Those with balance problems and gait impairments are at higher risk for long term placement and death related to falls. Exercise interventions improve gait and balance in the elderly. In participants with existing AD, physical activity has shown to prevent further cognitive decline and improve quality of life and prevent falls. However, it is difficult to engage patients with AD in long term exercise programs. The expense of physical therapy limits its easy accessibility. Use of everyday technology might bridge this gap by providing high level of engagement via the use of multimedia while providing a cost-effective alternative. Wii Fit is one such multimedia platform. Wii fit is a Nintendo gaming console used for aerobics, strength training and balance activities. This device includes a balance board that senses weight and shifts in movement and balance. Virtual trainers talk the user through the activity while tracking the user's progress. The investigators propose an 8-week prospective randomized study with the treatment group receiving the exercise program delivered by Wii-Fit system and the comparison arm receiving a walking exercise program in a community dwelling setting. Subjects in each arm will participate for 30 minutes daily five days a week.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Exergaming for dementia and mild cognitive impairment.
Voinescu A, Papaioannou T, Petrini K, Stanton Fraser D. · · 2024 · cited 9× · PMID 39319863 · DOI 10.1002/14651858.cd013853.pub2

Verify or expand the search:

Other trials of Wii-Fit intervention

Trials testing the same drug.

NCT01000038 — Wii-fit for Activity, Balance and Gait in Assisted Living · NA · completed

Other recruiting trials for Alzheimer's Dementia

Currently open trials in the same condition.

NCT07249918 — Feasibility of Wearables in Dementia Care in Rural Taiwan · NA · recruiting
NCT06534723 — Phase 3 Clinical Trial of Wujia Yizhi Granules in the Treatment of Mild-to-moderate Alzheimer's Dementia (Syndrome of De · Phase 3 · recruiting

Other University of Nebraska trials

Trials by the same sponsor.

NCT07507006 — Feasibility Study of the Flash-Sole: A Wearable Midsole With Soft Actuators for Walking Assistance · NA · not yet recruiting
NCT07517705 — MRD-Adapted Low-Dose Radiation Therapy During Frontline Chemoimmunotherapy for Diffuse Large B-Cell Lymphoma · NA · not yet recruiting
NCT07506993 — Inflammation in Clear Aligners With and Without Attachments · not yet recruiting
NCT07207850 — Parents Helping Parents for Youth Vaping Cessation · NA · not yet recruiting
NCT07237269 — Abi/Pred + ADT vs ADT in PSMA-Positive, Conventionally Node-Negative Prostate Cancer · Phase 2 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT01002586 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Nebraska
Last refreshed: 2 April 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01002586.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing